CT of deep venous thrombosis and pulmonary embolus

Does iso-osmolar contrast agent improve vascular opacification?

Lawrence R. Goodman, Meltem Gulsun, Paul G Nagy, Lacey Washington

Research output: Contribution to journalArticle

Abstract

PURPOSE: To prospectively compare the vascular attenuation achieved with the iso-osmolar dimeric contrast agent iodixanol with that achieved with the nonionic monomeric contrast agent iohexol for computed tomographic (CT) venography after CT pulmonary angiography. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained, and 51 consecutive patients undergoing CT pulmonary angiography and CT venography were recruited. A 130-mL dose of iodixanol 320 was injected intravenously at a rate of 4 mL/sec and followed by injection of 50 mL of saline. CT venography was performed after 3.5 minutes. From prior studies, 51 patients of similar weight were picked as control subjects. They received a similar iodine load with iohexol 300 and were studied with a similar technique. Section thickness was 1.25 mm for pulmonary emboli and 5 mm for deep venous thrombosis. Test and control group characteristics (ie, sex, age, and weight) were not significantly different (P > .05). Additionally, in test patients who had undergone CT pulmonary angiography and CT venography during the two preceding years, current and previously obtained CT scans were compared (ie, paired studies). Regions of interest were measured in four pulmonary artery and four lower extremity vein locations by two independent observers. RESULTS: Iodixanol increased average attenuation by 7 HU (P <.05) in the lower extremities and decreased average attenuation by 42 HU (P <.05) in the pulmonary arteries. In the 11 paired studies, similar results were obtained. CONCLUSION: Iodixanol caused a modest but statistically significant improvement in venous attenuation and a decrease in arterial attenuation. The diagnostic importance of this small increase in venous attenuation is not clear.

Original languageEnglish (US)
Pages (from-to)923-928
Number of pages6
JournalRadiology
Volume234
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Phlebography
Embolism
Venous Thrombosis
Contrast Media
Blood Vessels
Iohexol
Lung
Angiography
Pulmonary Artery
Lower Extremity
Weights and Measures
Research Ethics Committees
Informed Consent
Sex Characteristics
Iodine
Veins
Control Groups
Injections
iodixanol

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

CT of deep venous thrombosis and pulmonary embolus : Does iso-osmolar contrast agent improve vascular opacification? / Goodman, Lawrence R.; Gulsun, Meltem; Nagy, Paul G; Washington, Lacey.

In: Radiology, Vol. 234, No. 3, 03.2005, p. 923-928.

Research output: Contribution to journalArticle

Goodman, Lawrence R. ; Gulsun, Meltem ; Nagy, Paul G ; Washington, Lacey. / CT of deep venous thrombosis and pulmonary embolus : Does iso-osmolar contrast agent improve vascular opacification?. In: Radiology. 2005 ; Vol. 234, No. 3. pp. 923-928.
@article{b24e9d66c4ac460b90e1632ead75bf9c,
title = "CT of deep venous thrombosis and pulmonary embolus: Does iso-osmolar contrast agent improve vascular opacification?",
abstract = "PURPOSE: To prospectively compare the vascular attenuation achieved with the iso-osmolar dimeric contrast agent iodixanol with that achieved with the nonionic monomeric contrast agent iohexol for computed tomographic (CT) venography after CT pulmonary angiography. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained, and 51 consecutive patients undergoing CT pulmonary angiography and CT venography were recruited. A 130-mL dose of iodixanol 320 was injected intravenously at a rate of 4 mL/sec and followed by injection of 50 mL of saline. CT venography was performed after 3.5 minutes. From prior studies, 51 patients of similar weight were picked as control subjects. They received a similar iodine load with iohexol 300 and were studied with a similar technique. Section thickness was 1.25 mm for pulmonary emboli and 5 mm for deep venous thrombosis. Test and control group characteristics (ie, sex, age, and weight) were not significantly different (P > .05). Additionally, in test patients who had undergone CT pulmonary angiography and CT venography during the two preceding years, current and previously obtained CT scans were compared (ie, paired studies). Regions of interest were measured in four pulmonary artery and four lower extremity vein locations by two independent observers. RESULTS: Iodixanol increased average attenuation by 7 HU (P <.05) in the lower extremities and decreased average attenuation by 42 HU (P <.05) in the pulmonary arteries. In the 11 paired studies, similar results were obtained. CONCLUSION: Iodixanol caused a modest but statistically significant improvement in venous attenuation and a decrease in arterial attenuation. The diagnostic importance of this small increase in venous attenuation is not clear.",
author = "Goodman, {Lawrence R.} and Meltem Gulsun and Nagy, {Paul G} and Lacey Washington",
year = "2005",
month = "3",
doi = "10.1148/radiol.2343031871",
language = "English (US)",
volume = "234",
pages = "923--928",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - CT of deep venous thrombosis and pulmonary embolus

T2 - Does iso-osmolar contrast agent improve vascular opacification?

AU - Goodman, Lawrence R.

AU - Gulsun, Meltem

AU - Nagy, Paul G

AU - Washington, Lacey

PY - 2005/3

Y1 - 2005/3

N2 - PURPOSE: To prospectively compare the vascular attenuation achieved with the iso-osmolar dimeric contrast agent iodixanol with that achieved with the nonionic monomeric contrast agent iohexol for computed tomographic (CT) venography after CT pulmonary angiography. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained, and 51 consecutive patients undergoing CT pulmonary angiography and CT venography were recruited. A 130-mL dose of iodixanol 320 was injected intravenously at a rate of 4 mL/sec and followed by injection of 50 mL of saline. CT venography was performed after 3.5 minutes. From prior studies, 51 patients of similar weight were picked as control subjects. They received a similar iodine load with iohexol 300 and were studied with a similar technique. Section thickness was 1.25 mm for pulmonary emboli and 5 mm for deep venous thrombosis. Test and control group characteristics (ie, sex, age, and weight) were not significantly different (P > .05). Additionally, in test patients who had undergone CT pulmonary angiography and CT venography during the two preceding years, current and previously obtained CT scans were compared (ie, paired studies). Regions of interest were measured in four pulmonary artery and four lower extremity vein locations by two independent observers. RESULTS: Iodixanol increased average attenuation by 7 HU (P <.05) in the lower extremities and decreased average attenuation by 42 HU (P <.05) in the pulmonary arteries. In the 11 paired studies, similar results were obtained. CONCLUSION: Iodixanol caused a modest but statistically significant improvement in venous attenuation and a decrease in arterial attenuation. The diagnostic importance of this small increase in venous attenuation is not clear.

AB - PURPOSE: To prospectively compare the vascular attenuation achieved with the iso-osmolar dimeric contrast agent iodixanol with that achieved with the nonionic monomeric contrast agent iohexol for computed tomographic (CT) venography after CT pulmonary angiography. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained, and 51 consecutive patients undergoing CT pulmonary angiography and CT venography were recruited. A 130-mL dose of iodixanol 320 was injected intravenously at a rate of 4 mL/sec and followed by injection of 50 mL of saline. CT venography was performed after 3.5 minutes. From prior studies, 51 patients of similar weight were picked as control subjects. They received a similar iodine load with iohexol 300 and were studied with a similar technique. Section thickness was 1.25 mm for pulmonary emboli and 5 mm for deep venous thrombosis. Test and control group characteristics (ie, sex, age, and weight) were not significantly different (P > .05). Additionally, in test patients who had undergone CT pulmonary angiography and CT venography during the two preceding years, current and previously obtained CT scans were compared (ie, paired studies). Regions of interest were measured in four pulmonary artery and four lower extremity vein locations by two independent observers. RESULTS: Iodixanol increased average attenuation by 7 HU (P <.05) in the lower extremities and decreased average attenuation by 42 HU (P <.05) in the pulmonary arteries. In the 11 paired studies, similar results were obtained. CONCLUSION: Iodixanol caused a modest but statistically significant improvement in venous attenuation and a decrease in arterial attenuation. The diagnostic importance of this small increase in venous attenuation is not clear.

UR - http://www.scopus.com/inward/record.url?scp=13844320746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844320746&partnerID=8YFLogxK

U2 - 10.1148/radiol.2343031871

DO - 10.1148/radiol.2343031871

M3 - Article

VL - 234

SP - 923

EP - 928

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -